Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.
about
Novel methodologies for biomarker discovery in atherosclerosisOxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathologyCirculating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseasesInflammatory pain control by blocking oxidized phospholipid-mediated TRP channel activation.Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsCirculating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies.Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trialAntisense inhibition of apolipoprotein (a) to lower plasma lipoprotein (a) levels in humansAcute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable anginaMD-2 binds cholesterol.Liberating Chiral Lipid Mediators, Inflammatory Enzymes, and LIPID MAPS from Biological Grease.Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in Humans.Oxidized cholesteryl esters and inflammation.Context-Dependent Role of Oxidized Lipids and Lipoproteins in Inflammation.Identification of a novel series of anti-inflammatory and anti-oxidative phospholipid oxidation products containing the cyclopentenone moiety in vitro and in vivo: Implication in atherosclerosis.Lipoprotein(a) hyperlipidemia as cardiovascular risk factor: pathophysiological aspects.Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up.Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.Structure Annotation and Quantification of Wheat Seed Oxidized Lipids by High-Resolution LC-MS/MS.Antinociception by the anti-oxidized phospholipid antibody E06.Apolipoprotein AI prevents regulatory to follicular helper T cell switching during atherosclerosis.Oxidized phosphatidylcholines are produced in renal ischemia reperfusion injury.Deciphering the Role of Lipid Droplets in Cardiovascular Disease: A Report From the 2017 National Heart, Lung, and Blood Institute Workshop
P2860
Q28088373-1FCE548B-C01E-4C41-8820-9A77DFE5AB8EQ28397441-38982DE7-2ACF-429F-8AD9-90F882D4F609Q33597486-0264BCAE-ACDD-4520-8E3F-D7FA06C15228Q33633974-278500A6-D803-4600-8565-66B91FAD3576Q33906276-1CC9144C-1FD6-45BA-8248-0E9C0B125D66Q34518372-8F17A026-2B32-4C11-B20C-CC984DD94472Q35014306-9048CCB7-0F18-4773-B74B-8C6FAABC5E19Q35070934-B4639BB5-7FD3-439E-B905-E53E085F266FQ35130714-BADC11C7-9197-4162-AB02-FC094E90BE84Q35276226-B533B0DB-A25D-4DE7-A73E-BA5533CFD0D9Q36617508-CC2F652F-2C7E-4446-B77E-466A1648A00DQ36739679-288E4842-1F96-48AE-9ED4-181A2451DE15Q37025111-DA1C0C0C-4DF1-40DA-B1BC-AD21C6CE712EQ37421407-7DBF8ED9-CA18-49AD-94B4-F256C35E2911Q38389141-A3B44FA2-707D-4423-9890-6461344F26D0Q38883470-964714B8-737E-44A5-ABFF-9B5EB3770E6AQ39033338-66F9BB9B-85BF-4CCC-AE77-9CFCF47A55F3Q42775756-78ECFC78-3C8E-433C-884C-339E0F89CF63Q43188537-CCE0BDCF-0FC4-4E43-A6E0-357873713455Q45252610-5584CEA0-ECC4-4AC9-B6B9-457880D68A23Q46229988-2F321AFA-AC6D-4A52-9DF2-BB4FC789A268Q48250772-66B586E1-1538-43E5-9DC4-AE9908ECEB99Q52313596-4DE5E388-4227-4A5A-940D-14E1F6C5142BQ52726244-A0CF055E-47E3-490E-B658-6919D685F912Q55431412-91DB1CE5-4744-47D3-85EE-EA1589E8716EQ57175613-2B8194FF-06BA-441B-B5FF-7F5974BC58A1
P2860
Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Release and capture of bioacti ...... erial interventions in humans.
@ast
Release and capture of bioacti ...... erial interventions in humans.
@en
type
label
Release and capture of bioacti ...... erial interventions in humans.
@ast
Release and capture of bioacti ...... erial interventions in humans.
@en
prefLabel
Release and capture of bioacti ...... erial interventions in humans.
@ast
Release and capture of bioacti ...... erial interventions in humans.
@en
P2093
P2860
P50
P1476
Release and capture of bioacti ...... erial interventions in humans.
@en
P2093
Amir Ravandi
Anand Prasad
Ehtisham Mahmud
Ming-Yow Hung
Mitul Patel
Patrick M Hutchins
Yury I Miller
P2860
P304
P356
10.1016/J.JACC.2014.01.055
P407
P577
2014-03-05T00:00:00Z